Prescription Atorvastatin Calcium Tablets Recalled for Failed Quality Specifications
Dr. Reddy's Laboratories is recalling 28,068 bottles of Atorvastatin Calcium 80 mg tablets nationwide due to failed impurity and degradation specifications. No illnesses or injuries have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall with no reported illnesses or injuries. The manufacturing quality issue involves impurities and degradation that failed specifications, representing a precautionary recall without evidence of actual patient harm.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Atorvastatin Calcium tablets, 80 mg strength, in bottles of 90 tablets. Approximately 28,068 bottles were distributed nationwide in the United States.
The recall was initiated because certain lots failed to meet specifications for related substance impurities and degradation. The affected lots are: T000707, T000756, T000758, T000759 (expiration 03/2022); T2100600, T2101075 (expiration 1/2023); and T2102802 (expiration 07/2023).
Atorvastatin Calcium is a prescription medication used to lower cholesterol. Patients taking this medication from the affected lots should contact their healthcare provider or pharmacist for guidance. They should not discontinue the medication without consulting their healthcare provider first. No illnesses or injuries have been reported in connection with this recall.
The recalled product
- Product
- ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)
- Brand
- ATORVASTATIN CALCIUM
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug — Generic Statin
- Hazard
- impurities
- degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot: T000707
- T000756
- T000758
- T000759
- Exp 03/2022
- T2100600
- T2101075
- Exp. 1/2023
- T2102802
- Exp. 07/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ATORVASTATIN CALCIUM
- ModerateAtorvastatin Calcium Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2025-10-22
- ModerateAtorvastatin Calcium tablets recalled nationwide for failed dissolution specifications
FDA (Drugs) · 2025-10-22
- HighAtorvastatin Calcium Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2025-10-22
- ModerateAtorvastatin Calcium Tablets Recalled Due to Failed Dissolution Specifications
FDA (Drugs) · 2025-10-22
- HighBiocon Pharma atorvastatin calcium tablets recalled for failed dissolution specifications
FDA (Drugs) · 2025-04-09
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27